www.oradesibiu.ro/2026/11/12/cancerul-de-san-depis

Researchers have identified aggressive cells that survive treatment, allowing for an 81% accuracy in predicting cancer recurrence. An international team has developed a blood test for early breast cancer detection and assessing recurrence risk. The findings were published in Nature, with the Weizmann Institute of Science announcing results on November 11, 2026. The analysis detects tiny traces of cancer cells in the blood by tracking chemical markers that reflect their behavior. A specific group of aggressive cells can persist even when the cancer appears benign, making their identification crucial for monitoring post-treatment.